Data / Form D filings / Reiley Pharmaceuticals, Inc.
Reiley Pharmaceuticals, Inc.: Form D filings
Reiley Pharmaceuticals, Inc., a pharmaceuticals company in San Francisco, CA, filed 8 Form D notices with the SEC between 2014 and 2024. The latest, on June 5, 2024, reports $97,655 sold of a $247,132 offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3749 BUCHANAN STREET, SUITE 475745, San Francisco, CA, 94147
- Phone
- (650) 269-8044
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1616308
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 5, 2024 | New notice | $247,132 | $97,655 | $149,477 | 6 | May 31, 2024 | sec.gov |
| Oct 19, 2022 | Amendment | $447,132 | $100,000 | $347,132 | 2 | Oct 12, 2022 | sec.gov |
| Oct 18, 2022 | New notice | $447,132 | $100,000 | $347,132 | 2 | Oct 12, 2022 | sec.gov |
| Aug 3, 2020 | New notice | $1,500,000 | $1,052,868 | $447,132 | 27 | Jul 21, 2020 | sec.gov |
| Oct 24, 2019 | New notice | $400,000 | $0 | $400,000 | 0 | Yet to occur | sec.gov |
| Nov 7, 2017 | New notice | $1,200,000 | $1,200,000 | 19 | Nov 6, 2017 | sec.gov | |
| Jan 6, 2016 | New notice | $2,500,000 | $1,100,000 | $1,400,000 | 20 | Dec 22, 2015 | sec.gov |
| Aug 29, 2014 | New notice | $1,250,000 | $980,000 | $270,000 | 15 | Aug 15, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Keith Michael Valentine | Director | |
| Jeffrey Michael Dunn | Director | |
| B. Michael Silber | Director | |
| Donald Michael Kiepert | Executive Officer, Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jun 3, 2024 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Reiley Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.